Skip to main content
. 2021 Aug 8;10(8):2028. doi: 10.3390/cells10082028

Figure 3.

Figure 3

Kynurenine monooxygenase in GBM tissue. (A) KMO mRNA copy number in tissue samples: patients diagnosed with a neurological disease (control, n = 6) versus patients diagnosed with grade II to IV astrocytoma (glioma, n = 9). (B) Determination of KMO activity by quantification of 3-HK levels after 2 h incubation of the same samples used for KMO expression. Data are shown with the median (horizontal line); * p < 0.05 based on the Mann–Whitney test.